journal
MENU ▼
Read by QxMD icon Read
search

Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada

journal
https://www.readbyqxmd.com/read/28652883/conna%C3%A3-tre-sa-date-%C3%A2-meilleur-avant-%C3%A2-actualit%C3%A3-s-auc-pr%C3%A3-paration-d%C3%A2-un-plan-de-sortie
#1
J Curtis Nickel
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652882/legendary-urologist-yosh-taguchi-retires
#2
Mike Cohen
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652881/taking-the-first-steps-in-establishing-recommendations-for-testosterone-monitoring-in-men-with-prostate-cancer-on-androgen-deprivation-therapy
#3
Alvaro Morales
The paper by Shayegan et al in this issue of CUAJ represents an important initial step in establishing recommendations for hormonal monitoring in men with prostate cancer on androgen-deprivation therapy (ADT). As with most subjects related to the actions of testosterone, the survey adds to the controversies, but also opens the opportunity to explore several of the concerns relevant to the hormonal management of prostate cancer.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652880/testosterone-monitoring-for-men-with-advanced-prostate-cancer-review-of-current-practices-and-a-survey-of-canadian-physicians
#4
REVIEW
Bobby Shayegan, Frédéric Pouliot, Alan So, John Fernandes, Joseph Macri
Androgen-deprivation therapy (ADT) is a standard of care in the treatment of advanced prostate cancer; however, testosterone monitoring practices for men undergoing ADT vary across Canada. Although a testosterone level of 1.7 nmol/L or lower has historically been defined as the accepted castrate level, newer assays with improved sensitivity have shown that both medical and surgical castration can suppress testosterone levels to below 0.7 nmol/L. This review explores the evidence supporting a redefinition of the castrate testosterone level as 0...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652879/are-renal-tumour-scoring-systems-better-than-clinical-judgement-at-predicting-partial-nephrectomy-complexity
#5
Ravi M Kumar, Luke T Lavallée, Darren Desantis, Sonya Cnossen, Ranjeeta Mallick, Ilias Cagiannos, Chris Morash, Rodney H Breau
INTRODUCTION: We aimed to determine how renal tumour scoring systems, such as RENAL, PADUA, and Centrality (C)-index, compare to clinical judgement at predicting time required for tumour removal and kidney reconstruction during partial nephrectomy. METHODS: A consecutive cohort of partial nephrectomy patients treated at The Ottawa Hospital, a tertiary care uro-oncological centre, was retrospectively reviewed. Preoperative axial images were reviewed by four experienced urological oncologists who independently rated the complexity of a partial nephrectomy from 1-10 to generate a clinical judgement score...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652878/randomized-controlled-trial-of-laser-vs-bipolar-plasma-vaporization-treatment-of-benign-prostatic-hyperplasia
#6
Thomas A A Skinner, Robert J Leslie, Stephen S Steele, J Curtis Nickel
INTRODUCTION: Prostate vaporization technology is becoming a standard of care for treatment of moderate, symptomatic benign prostatic hyperplasia (BPH). We compared two transurethral prostate vaporization technologies with respect to cost, efficiency, efficacy, safety, and surgical team satisfaction. METHODS: Fifty-five patients meeting standardized symptom criteria for BPH were randomized to either Olympus Plasma Button(TM) or Biolitec EVOLVE(®) diode laser vaporization...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652877/pathology-review-impacts-clinical-management-of-patients-with-t1-t2-bladder-cancer
#7
Samer L Traboulsi, Fadi Brimo, Yutong Yang, Chelsea Maedler, Noémie Prévost, Simon Tanguay, Armen G Aprikian, Wassim Kassouf
INTRODUCTION: We sought to evaluate the contemporary role of a pathology review on management implications of patients with bladder cancer. METHODS: A total of 98 consecutive specimens from transurethral resections in patients with suspected bladder tumours were reviewed at our institution by genitourinary pathologist. Patients were classified into risk groups according to pathology reports obtained before and after review. A management course was proposed according to local institutional practice patterns and main urological guidelines...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652876/positive-surgical-margins-during-partial-nephrectomy-for-renal-cell-carcinoma-results-from-canadian-kidney-cancer-information-system-ckcis-collaborative
#8
Rahul K Bansal, Simon Tanguay, Antonio Finelli, Ricardo Rendon, Ronald B Moore, Rodney H Breau, Louis Lacombe, Peter C Black, Jun Kawakami, Darrel Drachenberg, Stephen Pautler, Olli Saarela, Zhihui Liu, Michael A S Jewett, Anil Kapoor
INTRODUCTION: We sought to determine the incidence, risk factors, and prognosis for patients with positive surgical margin (PSM) during partial nephrectomy (PN) for renal cell carcinoma (RCC). METHODS: From the Canadian Kidney Cancer information system (CKCis) database, a historical cohort of PN patients with PSM were identified and compared to negative surgical margin (NSM). Risk factors for PSM were examined through multivariable logistic regression. Kaplan-Meier curves were used to compare progression-free survival...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652875/contemporary-cost-consequence-analysis-of-blue-light-cystoscopy-with-hexaminolevulinate-in-non-muscle-invasive-bladder-cancer
#9
Zachary Klaassen, Kathy Li, Wassim Kassouf, Peter C Black, Alice Dragomir, Girish S Kulkarni
INTRODUCTION: Previous studies have suggested cost-savings using blue light cystoscopy (BLC) with hexaminolevulinate (HAL) compared to white light cystoscopy (WLC) during transurethral resection of bladder tumour (TURBT) for non-muscle-invasive bladder cancer (NMIBC), secondary to improvements in recurrence and progression rates; however, these studies have used 'best case scenario' recurrence rate probabilities, thus decreasing generalizability of the findings. The objective of this study was to perform a contemporary cost-effectiveness assessment of BLC compared to WLC at the time of TURBT...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652874/in-search-of-the-perfect-model
#10
Blayne Welk
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652873/the-value-of-complementing-administrative-data-with-abstracted-information-on-smoking-and-obesity-a-study-in-kidney-cancer
#11
Madhur Nayan, Robert J Hamilton, Antonio Finelli, Peter C Austin, Girish S Kulkarni, David N Juurlink
INTRODUCTION: Variables, such as smoking and obesity, are rarely available in administrative databases. We explored the added value of including these data in an administrative database study evaluating the association of statin use with survival in kidney cancer. METHODS: We linked administrative data with chart-abstracted data on smoking and obesity for 808 patients undergoing nephrectomy for kidney cancer. Base models consisted of variables from administrative databases (age, sex, year of surgery, and different measures of comorbidity [to compare their sensitivity to smoking and obesity data]); extended models added chart-abstracted data...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652872/exploring-the-business-of-urology-change-management
#12
J Stuart Oake, Timothy O Davies, Anne-Marie Houle, Darren Beiko
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652871/pursuing-fellowship-training-there-are-no-traffic-jams-along-the-extra-mile
#13
Zachary Klaassen
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652870/global-implementation-of-advanced-urological-care-policy-implementation-research
#14
Lynn Stothers, Andrew Macnab
INTRODUCTION: In high-resource countries, modern treatments for urological diseases have led to significant reductions in mortality and morbidity; however, the benefits of modern treatment have yet to reach the majority of people worldwide. As attention is focused on improving urological care in the global community, policy and implementation research (PIR) offers a platform for effective organization and engagement. METHODS: We have compiled a photo essay to illustrate the fundamental components of PIR...
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652869/knowing-our-best-before-date-developing-an-exit-plan
#15
J Curtis Nickel
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28652868/costs-innovation-and-change-management
#16
EDITORIAL
D Robert Siemens
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28620446/canadian-urological-association-72nd-annual-meeting-toronto-on-june-24-27-2017
#17
(no author information available yet)
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28616122/new-research-in-testicular-cancer-asco-gu-2017
#18
REVIEW
Robert J Hamilton, Christian Kollmansberger
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28616121/new-research-in-prostate-cancer-asco-gu-2017
#19
REVIEW
Kim Chi, Fred Saad
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
https://www.readbyqxmd.com/read/28616120/new-research-in-kidney-cancer-asco-gu-2017
#20
REVIEW
Naveen Basappa, Frederic Pouliot
No abstract text is available yet for this article.
June 2017: Canadian Urological Association Journal, Journal de L'Association des Urologues du Canada
journal
journal
41699
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"